Michael Lamprecht

Michael Lamprecht is an Investment Manager at Tenmile, a Sydney-based life sciences venture capital firm, where he assesses early-stage biotech and health-tech opportunities. He holds a PhD in biomedical engineering from Columbia University and a bachelor's degree in the same field from Boston University, and spent over a decade developing regulatory and clinical strategies for novel cell-based therapies. Before joining Tenmile he was Entrepreneur-in-Residence at Xora Innovation in Singapore and Director of Regulatory Affairs at EpiBone, a US biotech developing stem-cell-based bone and cartilage grafts. He also sits on the boards of Carina Biotech, Inventia Life Science and Revagenix. On What The Health, Lamprecht discussed cancer vaccines and the limits of consumer wearables.